Clinical trial
Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute…
NCT00245115 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Terminated
Key facts
| NCT number | NCT00245115 |
|---|---|
| Title | Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia |
| Official title | Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, busulfan, cyclophosphamide, in vitro-treated bone marrow transplantation, in vitro-treated peripheral blood stem cell transplantation |
| Enrollment | 7 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2012 |
| First posted | Oct 27, 2005 |
| Last update posted | Aug 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: